Semaglutide Research Reports

Long-acting GLP-1 analogue best known under the Ozempic and Wegovy brands. Members typically titrate slowly from 0.25 mg to a maintenance dose, holding at the lowest effective level to manage GI side effects.

Category: glp1

Common route: subcutaneous

Common Use Cases